- Netherlands
- /
- Chemicals
- /
- ENXTAM:HYDRA
Hydratec Industries Full Year 2022 Earnings: EPS: €12.31 (vs €11.70 in FY 2021)
Hydratec Industries (AMS:HYDRA) Full Year 2022 Results
Key Financial Results
- Revenue: €283.3m (up 10% from FY 2021).
- Net income: €15.9m (up 5.4% from FY 2021).
- Profit margin: 5.6% (down from 5.9% in FY 2021). The decrease in margin was driven by higher expenses.
- EPS: €12.31 (up from €11.70 in FY 2021).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Hydratec Industries shares are up 2.9% from a week ago.
Risk Analysis
We should say that we've discovered 1 warning sign for Hydratec Industries that you should be aware of before investing here.
Valuation is complex, but we're here to simplify it.
Discover if Hydratec Industries might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ENXTAM:HYDRA
Hydratec Industries
Through its subsidiaries, manufactures and sells industrial systems and plastic components for food, health, and mobility markets in the Netherlands, rest of Europe, Asia, North America, South America, Africa, and Oceania.
Flawless balance sheet established dividend payer.
Market Insights
Weekly Picks

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fiducian: Compliance Clouds or Value Opportunity?
Willamette Valley Vineyards (WVVI): Not-So-Great Value
Recently Updated Narratives
PRME remains a long shot but publication in the New England Journal of Medicine helps.
This one is all about the tax benefits
Estimated Share Price is $79.54 using the Buffett Value Calculation
Popular Narratives

MicroVision will explode future revenue by 380.37% with a vision towards success

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
